A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II

V.J. Harvey; K.J. Sharples; R.J. Isaacs; M.B. Jameson; G.M. Jeffery; B.R. McLaren; S. Pollard; G.A. Riley; A.B. Simpson; V.A. Hinder; J.N. Scott; M.V. Dzhelali; M.P. Findlay

doi:10.1093/annonc/mdt065

A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II

Annals of Oncology ◽

10.1093/annonc/mdt065 ◽

2013 ◽

Vol 24 (7) ◽

pp. 1828-1834 ◽

Cited By ~ 1

Author(s):

V.J. Harvey ◽

K.J. Sharples ◽

R.J. Isaacs ◽

M.B. Jameson ◽

G.M. Jeffery ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Oral Cyclophosphamide ◽

Randomized Phase Ii

Download Full-text

A randomized phase II study comparing capecitabine (C) with C plus oral cyclophosphamide (CCy) in patients (pts) with advanced breast cancer (BC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.1077 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 1077-1077

Author(s):

V. J. Harvey ◽

K. Sharples ◽

R. Isaacs ◽

M. B. Jameson ◽

M. Jeffery ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Oral Cyclophosphamide ◽

Randomized Phase Ii

Download Full-text

346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover

European Journal of Cancer ◽

10.1016/0959-8049(95)95599-2 ◽

1995 ◽

Vol 31 ◽

pp. S75 ◽

Cited By ~ 1

Author(s):

R. Paridaens ◽

P. Bruning ◽

F. Calabresi ◽

A. Awada ◽

J.A. Roy ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

First Line ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Abstract CT101: Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)

10.1158/1538-7445.am2014-ct101 ◽

2014 ◽

Cited By ~ 23

Author(s):

Richard S. Finn ◽

John P. Crown ◽

Istvan Lang ◽

Katalin Boer ◽

Igor M. Bondarenko ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Cyclin Dependent Kinase ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

A randomized phase II study of pemetrexed-carboplatin and gemcitabine-vinorelbine in patients with anthracycline- and taxane-pretreated advanced breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.1051 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 1051-1051 ◽

Cited By ~ 1

Author(s):

D. Amadori ◽

I. La Torre ◽

E. M. Carrasco ◽

S. Roesel ◽

R. Labianca ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Randomized Phase Ii

Download Full-text

Abstract P1-14-01: Final results of NorBreast-231, a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel as first-line chemotherapy in patients with advanced breast cancer

10.1158/1538-7445.sabcs18-p1-14-01 ◽

2019 ◽

Author(s):

MS Aapro ◽

R Hegg ◽

M Ruiz Borrego ◽

E Staroslawska ◽

S Morales ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

First Line ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor-positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial)

The Breast ◽

10.1016/j.breast.2019.01.009 ◽

2019 ◽

Vol 45 ◽

pp. 7-14 ◽

Cited By ~ 2

Author(s):

Matti Aapro ◽

Manuel Ruiz-Borrego ◽

Roberto Hegg ◽

Bozena Kukielka-Budny ◽

Serafin Morales ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Estrogen Receptor Positive

Download Full-text

Randomized phase II study of FEC day 1 + 8 and FEC day 1 in patients with advanced breast cancer

Breast Cancer Research and Treatment ◽

10.1023/a:1006359130081 ◽

2000 ◽

Vol 60 (1) ◽

pp. 57-62 ◽

Cited By ~ 2

Author(s):

D.W. van Toorn ◽

J.W.R Nortier ◽

M. Rubach ◽

C.A.M. de Swart ◽

J.C. Huldij ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Randomized Phase Ii

Download Full-text

Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)

European Journal of Cancer ◽

10.1016/j.ejca.2021.11.010 ◽

2022 ◽

Vol 161 ◽

pp. 26-37

Author(s):

J. Albanell ◽

M.T. Martínez ◽

M. Ramos ◽

M. O'Connor ◽

L. de la Cruz-Merino ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Advanced Breast ◽

Hormone Receptor Positive ◽

Randomized Phase Ii

Download Full-text

Randomised phase II study comparing capecitabine with oral cyclophosphamide and capecitabine in patients with advanced breast cancer

http://isrctn.org/> ◽

10.1186/isrctn68662102 ◽

2012 ◽

Author(s):

Vernon Harvey

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Oral Cyclophosphamide

Download Full-text

MonarcHER: A randomized phase II study of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+ advanced breast cancer (ABC)

Annals of Oncology ◽

10.1093/annonc/mdz394.012 ◽

2019 ◽

Vol 30 ◽

pp. v861-v862 ◽

Cited By ~ 10

Author(s):

S.M. Tolaney ◽

A.M. Wardley ◽

S. Zambelli ◽

J. Hilton ◽

T. Troso-Sandoval ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Standard Of Care ◽

Advanced Breast ◽

Randomized Phase Ii

Download Full-text